Effects of Bloodletting Acupuncture for Subacute and Chronic Non-specific Low Back Pain
NCT ID: NCT06190366
Last Updated: 2024-01-05
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
RECRUITING
NA
108 participants
INTERVENTIONAL
2023-12-19
2025-12-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Efficacy of Acupuncture for Discogenic Sciatica
NCT02770963
Battlefield Acupuncture for the Treatment of Low Back Pain in the Emergency Department
NCT02399969
Prolotherapy in Acupoints in Chronic Non-specific Low Back Pain (cLBP)
NCT07296653
Brain Mechanisms of Acupuncture Treatment in Chronic Low Back Pain
NCT01595451
Acupuncture to Reduce Signs of Inflammation in Participants With Chronic Low Back Pain
NCT01376375
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
PARALLEL
TREATMENT
SINGLE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Bloodletting acupuncture at the fossa poplitea
Bloodletting acupuncture at the fossa poplitea
This group is treated with bloodletting acupuncture at the fossa poplitea. The treatment takes place twice a week from week 1 to week 3. This means that 6 treatments of approx. 20 minutes each should be carried out within the 3 weeks.
Bloodletting acupuncture at the regio glutaea
Bloodletting acupuncture at the regio glutaea
This group is treated with bloodletting acupuncture at the regio glutaea. The treatment takes place twice a week from week 1 to week 3. This means that 6 treatments of approx. 20 minutes each should be carried out within the 3 weeks.
Waiting list control group
No interventions assigned to this group
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Bloodletting acupuncture at the fossa poplitea
This group is treated with bloodletting acupuncture at the fossa poplitea. The treatment takes place twice a week from week 1 to week 3. This means that 6 treatments of approx. 20 minutes each should be carried out within the 3 weeks.
Bloodletting acupuncture at the regio glutaea
This group is treated with bloodletting acupuncture at the regio glutaea. The treatment takes place twice a week from week 1 to week 3. This means that 6 treatments of approx. 20 minutes each should be carried out within the 3 weeks.
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Average pain intensity with at least 50 mm on the VAS from 0 to 100 mm
Exclusion Criteria
* Poor general condition
* Coagulation disorder, therapy with anticoagulants
* Thrombophlebitis, skin inflammation in the area of the lower extremities
* Alcohol, drug or medication addiction
* Pregnancy
* Lack of willingness to cooperate, linguistically or mentally unable to understand the contents of the study
* Participation in another clinical trial during the study period
* Starting a new therapy for the treatment of low back pain in the last 2 weeks
18 Years
65 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Charite University, Berlin, Germany
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Andreas Michalsen
Principal Investigator
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Charité Hochschulambulanz für Naturheilkunde, Immanuel Krankenhaus Berlin
Berlin, , Germany
Countries
Review the countries where the study has at least one active or historical site.
Central Contacts
Reach out to these primary contacts for questions about participation or study logistics.
Facility Contacts
Find local site contact details for specific facilities participating in the trial.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
Mikroaderlass
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.